Chimeric antigen receptor (CAR) T cell-based therapy has greatly improved cancer treatment, especially for hematologic cancers. 1 By providing T cells with synthetic receptors that target tumor ...
Explore luminescence screening assays for drug discovery, including luciferase and ATP assays. Learn the principles, formats, ...
Metastases are a key problem in many types of cancer. As descendants of the primary tumor, they can grow in other organs distant from the primary site and are often difficult to identify. A research ...
Functional Characterization and a Real-World Clinical Laboratory Pilot of the Foundation for the National Institutes of Health Circulating Tumor DNA Quality Control Materials A total of 871 patient ...
Automate real-time, label-free cell assays with Maestro TrayZ. Capture dynamic cellular responses with high sensitivity and ...
BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
Morning Overview on MSN
Study links extra chromosome sets to tumor spread and cell mobility
Cancer cells that accumulate extra copies of their entire chromosome set can start behaving like immune cells, swallowing ...
Metrion Biosciences, today announced the launch of its validated, high-throughput NaV1.9 screening assay to advance discovery and development of novel pain therapeutics. Validated drug discovery assay ...
A study reveals how MLKL drives stem cell aging by damaging mitochondria without causing cell death, reducing regenerative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results